EP2916859

METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT UNDERGOING TREATMENT WITH A MEK INHIBITOR

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    1.11.2013
  • :
    28.6.2017
  • :
    13792162.3
  • :
    31.10.2033
  • :
    METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT UNDERGOING TREATMENT WITH A MEK INHIBITOR

1.11.2013
28.6.2017
  • :
    The U.S.A. as represented by the Secretary, Department of Health and Human Services
  • :
    Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325, MSC 7660, 20892-7660, Bethesda, MD, US
  • :
    Merck Patent GmbH
  • :
    Frankfurter Strasse 250, 64293, Darmstadt, DE
  • :
    MILLER, Sheldon S.
  • :
    Bethesda, MD, US
  • :
    MAMINISHKIS, Arvydas
  • :
    Washington, D.C., US
  • :
    REMÉ, Charlotte E.
  • :
    Zürich, CH
  • :
    201261721810 P
  • :
    2.11.2012
  • :
    US
  • :
    US2013068056
  • :
    1.11.2013
  • :
    A61K 38/21, A61P 27/00